Open access
Sep 2026
Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson's disease.
Toward development of an autologous, induced pluripotent stem cell (iPSC)-based cell therapy for Parkinson's disease (PD), we demonstrate successful, reproducible genomic and transcriptomic qualification of patient-derived dopaminergic neuron precursor cells (DANPCs) across multiple donors. Our analysis includes whole-...
Andres M. Bratt-Leal, T. Gorba, Roy M. Williams et al.
· Cell Stem Cell · 0 citations